Andrew Jackson

Vice President, Corporate Security
Novartis Corporation

Andrew Jackson is Vice President, Corporate Security, overseeing security operations for Novartis Group Companies in the United States, including Novartis Pharmaceuticals, Sandoz, Over the Counter, Novartis Animal Health, CIBA Vision, Novartis Vaccines & Diagnostics and Novartis Institutes of Biomedical Research. In this position since June 2008, Mr. Jackson manages and coordinates investigative and executive protection activities, manages technical security systems and physical security measures, develops security policies and procedures, and conducts periodic security audits of Novartis companies. Mr. Jackson also oversees the US Business Practices Office (BPO) and is responsible for managing Novartis's US-based Aviation Department and meeting security program.

Prior to joining Novartis in 2002 as Executive Director, Deputy Global Head Corporate Security, Mr. Jackson worked as a Regional Security Adviser for SGS AG from 1998 - 2002. Earlier in his career Andrew worked in the UK, Latin America and Eastern Europe for the British Diplomatic Service from 1985 - 1998.